REKVINA (10)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE revises price bands for 10 scrips ranging from 2% to 20% effective January 29, 2026, affecting securities under surveillance measures. | |||||||||||||||
BSE revises price bands for 10 scrips ranging from 2% to 20% effective January 29, 2026, affecting securities under surveillance measures.
| |||||||||||||||
BSE announces revised price bands for 10 securities ranging from 2% to 20%, effective January 29, 2026, as part of surveillance measures. | |||||||||||||||
BSE announces revised price bands for 10 securities ranging from 2% to 20%, effective January 29, 2026, as part of surveillance measures.
| |||||||||||||||
BSE announces securities being added to and continuing in the Long Term Additional Surveillance Measure (LT-ASM) framework effective January … | |||||||||||||||
BSE announces securities being added to and continuing in the Long Term Additional Surveillance Measure (LT-ASM) framework effective January 23, 2026.
| |||||||||||||||
BSE announces securities moving into and out of Long Term ASM Framework effective January 23, 2026, with four new securities shortlisted in … | |||||||||||||||
BSE announces securities moving into and out of Long Term ASM Framework effective January 23, 2026, with four new securities shortlisted in LT-ASM.
| |||||||||||||||
Rekvina Laboratories Ltd. equity shares will be moved to 'X' group effective January 20, 2026. | |||||||||||||||
Rekvina Laboratories Ltd. equity shares will be moved to 'X' group effective January 20, 2026.
| |||||||||||||||
Rekvina Laboratories Ltd. equity shares to be moved to 'X' group effective January 20, 2026. | |||||||||||||||
Rekvina Laboratories Ltd. equity shares to be moved to 'X' group effective January 20, 2026.
| |||||||||||||||
BSE revokes the suspension in trading of equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to … | |||||||||||||||
BSE revokes the suspension in trading of equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to resume.
| |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to … | |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to resume.
| |||||||||||||||
BSE revokes the trading suspension on equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing trading to resume. | |||||||||||||||
BSE revokes the trading suspension on equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing trading to resume.
| |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to … | |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to resume.
| |||||||||||||||